Now showing items 1-1 of 1
Merkel cell polyomavirus-specific CD8 T cells in Merkel cell carcinoma: T cell receptor diversity & novel immune therapies
Merkel cell carcinoma (MCC) is an aggressive skin cancer with a disease-specific mortality of 46%. Unfortunately, no FDA-approved treatments for advanced disease exist. Over 80% of MCCs are caused by persistent expression of T-antigen oncoproteins from the Merkel cell polyomavirus (MCPyV). Systemic immunity is strongly linked ...